Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Acne Vulgaris Market By Therapeutic Class ), Antibiotic, Salicylic Acid, Benzoyl Peroxide, and Others), By Product, By Formulation, By Acne Type, By Distribution Channel, and Geography
Acne Vulgaris Market Size was valued at US$ 9.2 billion in 2023 and is poised to grow at a significant CAGR of 5.1% from 2024-2030. Acne vulgaris is a very common chronic skin condition involving blockage or inflammation of the sebaceous gland. It occurs mostly in teenagers and young adults. Pus-filled pimples, inflame, red bumps, and uninflamed blackheads are very common symptoms of acne vulgaris. Treatment includes over-the-counter creams, cleansers, retinoids, antibiotics, salicylic acid, and benzoyl peroxide.
The rising prevalence of acne among teenagers & young adults is driving the global market of acne vulgaris. For instance, according to NCBI, Acne is estimated to affect 9.4% of the global population, making it the eighth most prevalent disease worldwide. Several clinical studies have reported a prevalence of adolescent acne ranging from 81 to 95 percent in young men and 79 to 82 percent in young women. Clinical approval & launch of new drugs are propelling the market growth. Despite all of the driving factors, some factors are limiting the market growth among them most influential restrain of the market is the side effects of acne treatment drugs. Some medications for acne vulgaris can cause severe allergic reactions, irritations, nausea, vomiting, etc.
Moreover, available treatment options and the introduction of new products for acne treatment such as retinoids, and antibiotics are increasing awareness all over the world. Efficient marketing is expected to propel the market. Also, hormonal therapy has potential growth opportunities in the future. The growing demand for hormonal therapies and recurring investments in the research and development sector for new drugs and therapies will exponentially grow the global acne vulgaris market. North America is dominating the market based on the region due to rising concerns about derma products.
Study Period
2024-2030Base Year
2023CAGR
5.1%Largest Market
Asia-PacificFastest Growing Market
North America
The increasing prevalence of chronic acne accelerated the global market of acne vulgaris. Acne is a highly prevalent skin disorder among teenagers and young adults. According to the Global Burden of Disease (GBD) study, acne vulgaris affects around 85% of teens and young adults aged 12-25 years. With the increase in adult acne conditions, the global acne vulgaris market will grow rapidly in the forecasted years. Acute acne patients are often suffer psychological issues like anxiety, depression, low self-esteem, poor quality of life, and loneliness. According to a Turkish study, it states that patients with acne were at increased risk for anxiety and depression compared to the normal population. The risk of anxiety and depression were 26.2% and 29.5%. These psychological issues are expected to fuel the growth of the global acne vulgaris market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 9.2 billion |
Market CAGR |
5.1% |
By Therapeutic Class |
|
By Product Type |
|
By Distribution Channel |
|
Download Free Sample Report
The acne vulgaris market is projected to expand at a CAGR of 5.1% during the forecast period
Galderma S.A., Pfizer, Allergan, Botanix pharmaceuticals, Sun Pharmaceutical industry
North America is the fastest-growing region for acne vulgaris market
1. Executive Summary |
2. Global Acne Vulgaris Market Introduction |
2.1. Global Acne Vulgaris Market Taxonomy |
2.2. Global Acne Vulgaris Market Definitions |
2.2.1. By Therapeutic Class |
2.2.2. By Product |
2.2.3. By Formulation |
2.2.4. By Acne Type |
2.2.5. By Distribution Channel |
2.2.6. By Region |
3. Global Acne Vulgaris Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Acne Vulgaris Market Dynamic Factors - Impact Analysis |
3.6. Global Acne Vulgaris Market Competition Landscape |
3.7. Epidemiology |
4. Global Acne Vulgaris Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Acne Vulgaris Market, By Therapeutic Class, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Retinoid |
5.1.1. Topical Retinoid & Combination Retinoid |
5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Oral Retinoid (Isotretinoin) |
5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.2. Antibiotic |
5.2.1. Topical Antibiotic & Combination Antibiotics |
5.2.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Oral Antibiotics |
5.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.3. Salicylic Acid |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Benzoyl Peroxide |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Acne Vulgaris Market, By Product, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. Mask |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Creams & Lotions |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Cleansers & Toners |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Acne Vulgaris Market, By Formulation, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. Topical Medication |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Oral Medication |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Global Acne Vulgaris Market, By Acne Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. Non-inflammatory acne |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Inflammatory acne |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9. Global Acne Vulgaris Market, By Acne Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. Retail Drug Store |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Hospital Pharmacies |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. E-Commerce |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
10. Global Acne Vulgaris Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. North America |
10.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.1.3. Market Opportunity Analysis |
10.2. Europe |
10.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.2.3. Market Opportunity Analysis |
10.3. Asia-Pacific |
10.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.3.3. Market Opportunity Analysis |
10.4. Latin America |
10.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.4.3. Market Opportunity Analysis |
10.5. Middle East and Africa |
10.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.5.3. Market Opportunity Analysis |
10.6. Global Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By distribution Channel and Region, 2024 - 2030 |
11. North America Acne Vulgaris Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Therapeutic Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Retinoid |
11.1.1.1. Topical Retinoid & Combination Retinoid |
11.1.1.2. Oral Retinoid (Isotretinoin) |
11.1.2. Antibiotic |
11.1.2.1. Topical Antibiotic & Combination Antibiotics |
11.1.2.2. Oral Antibiotics |
11.1.3. Salicylic Acid |
11.1.4. Benzoyl Peroxide |
11.1.5. Others |
11.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Mask |
11.2.2. Creams & Lotions |
11.2.3. Cleansers & Toners |
11.2.4. Others |
11.3. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Topical Medication |
11.3.2. Oral Medication |
11.4. Acne Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Non-inflammatory acne |
11.4.2. Inflammatory acne |
11.5. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Retail Drug Store |
11.5.2. Hospital Pharmacies |
11.5.3. E-Commerce |
11.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.6.1. USA |
11.6.2. Canada |
11.7. North America Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2024 - 2030 |
11.8. North America Acne Vulgaris Market Dynamics Trends |
12. Europe Acne Vulgaris Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Therapeutic Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Retinoid |
12.1.1.1. Topical Retinoid & Combination Retinoid |
12.1.1.2. Oral Retinoid (Isotretinoin) |
12.1.2. Antibiotic |
12.1.2.1. Topical Antibiotic & Combination Antibiotics |
12.1.2.2. Oral Antibiotics |
12.1.3. Salicylic Acid |
12.1.4. Benzoyl Peroxide |
12.1.5. Others |
12.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Mask |
12.2.2. Creams & Lotions |
12.2.3. Cleansers & Toners |
12.2.4. Others |
12.3. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Topical Medication |
12.3.2. Oral Medication |
12.4. Acne Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Non-inflammatory acne |
12.4.2. Inflammatory acne |
12.5. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Retail Drug Store |
12.5.2. Hospital Pharmacies |
12.5.3. E-Commerce |
12.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.6.1. Germany |
12.6.2. UK |
12.6.3. France |
12.6.4. Spain |
12.6.5. Italy |
12.6.6. Rest of Europe |
12.7. Europe Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2024 - 2030 |
12.8. Europe Acne Vulgaris Market Dynamics Trends |
13. Asia-Pacific Acne Vulgaris Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. Therapeutic Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Retinoid |
13.1.1.1. Topical Retinoid & Combination Retinoid |
13.1.1.2. Oral Retinoid (Isotretinoin) |
13.1.2. Antibiotic |
13.1.2.1. Topical Antibiotic & Combination Antibiotics |
13.1.2.2. Oral Antibiotics |
13.1.3. Salicylic Acid |
13.1.4. Benzoyl Peroxide |
13.1.5. Others |
13.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Mask |
13.2.2. Creams & Lotions |
13.2.3. Cleansers & Toners |
13.2.4. Others |
13.3. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Topical Medication |
13.3.2. Oral Medication |
13.4. Acne Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Non-inflammatory acne |
13.4.2. Inflammatory acne |
13.5. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Retail Drug Store |
13.5.2. Hospital Pharmacies |
13.5.3. E-Commerce |
13.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.6.1. China |
13.6.2. India |
13.6.3. Japan |
13.6.4. ASEAN |
13.6.5. Australia & New Zealand |
13.6.6. Rest of Asia-Pacific |
13.7. Asia-Pacific Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2024 - 2030 |
13.8. Asia-Pacific Acne Vulgaris Market Dynamics Trends |
14. Latin America Acne Vulgaris Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
14.1. Therapeutic Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Retinoid |
14.1.1.1. Topical Retinoid & Combination Retinoid |
14.1.1.2. Oral Retinoid (Isotretinoin) |
14.1.2. Antibiotic |
14.1.2.1. Topical Antibiotic & Combination Antibiotics |
14.1.2.2. Oral Antibiotics |
14.1.3. Salicylic Acid |
14.1.4. Benzoyl Peroxide |
14.1.5. Others |
14.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Mask |
14.2.2. Creams & Lotions |
14.2.3. Cleansers & Toners |
14.2.4. Others |
14.3. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Topical Medication |
14.3.2. Oral Medication |
14.4. Acne Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Non-inflammatory acne |
14.4.2. Inflammatory acne |
14.5. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Retail Drug Store |
14.5.2. Hospital Pharmacies |
14.5.3. E-Commerce |
14.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.6.1. Brazil |
14.6.2. Mexico |
14.6.3. Rest of Latin America |
14.7. Latin America Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2024 - 2030 |
14.8. Latin America Acne Vulgaris Market Dynamics Trends |
15. Middle East and Africa Acne Vulgaris Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
15.1. Therapeutic Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
15.1.1. Retinoid |
15.1.1.1. Topical Retinoid & Combination Retinoid |
15.1.1.2. Oral Retinoid (Isotretinoin) |
15.1.2. Antibiotic |
15.1.2.1. Topical Antibiotic & Combination Antibiotics |
15.1.2.2. Oral Antibiotics |
15.1.3. Salicylic Acid |
15.1.4. Benzoyl Peroxide |
15.1.5. Others |
15.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
15.2.1. Mask |
15.2.2. Creams & Lotions |
15.2.3. Cleansers & Toners |
15.2.4. Others |
15.3. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.3.1. Topical Medication |
15.3.2. Oral Medication |
15.4. Acne Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.4.1. Non-inflammatory acne |
15.4.2. Inflammatory acne |
15.5. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.5.1. Retail Drug Store |
15.5.2. Hospital Pharmacies |
15.5.3. E-Commerce |
15.6. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
15.6.1. Gulf Cooperation Council (GCC) Countries |
15.6.2. South Africa |
15.6.3. Rest of MEA |
15.7. MEA Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2024 - 2030 |
15.8. MEA Acne Vulgaris Market Dynamics Trends |
16. Competition Landscape |
16.1. Strategic Dashboard of Top Market Players |
16.2. Company Profiles (Introduction, Financial Analysis, Key Therapeutic Classes, Key Developments, Strategies, and SWOT Analysis) |
16.2.1. Galderma S.A. |
16.2.2. Pfizer |
16.2.3. Allergan |
16.2.4. Botanix pharmaceuticals |
16.2.5. Sun Pharmaceutical industry |
16.2.6. GlaxoSmithKline |
16.2.7. Alembic Pharmaceuticals |
16.2.8. Almirall, S.A |
16.2.9. Johnson & Johnson |
16.2.10. Bausch Health Companies |
16.2.11. Teva Pharmaceutical Industries Ltd. |
16.2.12. Candela Medical |
17. Research Methodology |
18. Key Assumptions and Acronyms |
Key Market Players